A Trump-ordered review of the scientific basis for providing “gender-affirming care” to kids — which found almost no medical evidence to support hormone therapy and other treatments for minors who identify as transgender — was published in its final version Wednesday after passing scientific peer review.

The report was reviewed by 10 different experts and research groups — and none identified major faults in the findings that US doctors should pause giving common gender dysphoria treatments until more is known about the long term effects on patients, the lead author told The Post.

“They were given the chance to show mistakes, show errors. And they were not able to identify any,” said Dr. Leor Sapir , a senior fellow at the Manhattan Institute and one of the project researchers.

“T

See Full Page